Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloi... (e AC220 from concept to lead candidate s...)

Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia

Date:12/11/2009

e AC220 from concept to lead candidate selection in only 18 months.

About Acute Myeloid Leukemia (AML)

Acute myeloid leukemia is a form of blood cancer. According to the American Cancer Society, approximately 13,000 new cases of AML will be diagnosed in the United States in 2008. The median age of a patient with AML is about 67 years. Standard treatment for patients 60 years or older with AML includes systemic combination chemotherapy. The median survival for patients receiving induction chemotherapy, which is associated with high mortality, is 6-11 months, with shorter survival for patients over the age of 60 years. The five-year survival rate for AML is less than 15 percent due to refractory and relapsed disease associated with standard treatments. According to a report from Decision Resources, the U.S. AML market is expected to more than double by 2015.

About Ambit Biosciences

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit employs a novel and proprietary kinase profiling technology, KINOMEscan(TM), to screen compounds against 442 human kinases.

Ambit's lead compound, AC220, is in clinical development for the treatment of AML and other indications. Ambit plans to commence in 2009 and 2010 several clinical studies with AC220, including a registration study in AML. Ambit's clinical pipeline also includes AC480, an oral pan-HER inhibitor that was in-licensed from BMS. Ambit is conducting Phase 2 studies with AC480 in patients with solid tumor cancers. Additionally, Ambit has an advancing pool of preclinical candidates targeting BRAF (in collaboration with Cephalon), JAK2, Aurora, and CSF1R. Through its KINOMEscan Division, Ambit markets its technology as a profiling service. For more information, visit '/>"/>

SOURCE Ambit Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT
2. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
3. Cell Biosciences Acquires Protein Forest
4. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
5. Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
6. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
7. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
8. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
9. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
10. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
11. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009

Post Your Comments:

(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...

(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...

(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...

(Date:6/18/2013)... 2013 AMRI (NASDAQ: AMRI ) ... , site has received approval to expand ... to handle Schedule 2 and 2N controlled substances. ... Burlington,s physical security and quality ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors [0] RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants [0] AMRI Burlington Receives DEA Approval to Handle Controlled Substances

... ANTONY, France, July 10 , - 1st Half-Year Sales Up 16%, - Revision Upwards of 2008 Sales Growth Guidance: (greater than or equal,to)12%, EUR millions ... 07/06 2008 08/07 ... ... Europe (1) 20.5 72 23.2 72 13 26.8 71 ...

... July 10 Today,s Pharmaceutical Research,and ... to end the practice,of providing non-educational ... toward,enhancing the value of the physician/industry ... CMR Institute, a leading non-profit,organization dedicated ...

... July 10 Quest Diagnostics,Incorporated (NYSE: DGX ), ... announced today that its second-quarter,2008 results will be made ... that it will hold its quarterly conference call with ... on that day., The public may access the ...

Cached Biology Technology:Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth 2 CMR Institute: Education Key to Physician/Representative Relationship 2 Quest Diagnostics to Release Second Quarter 2008 Financial Results 2

Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth CMR Institute: Education Key to Physician/Representative Relationship Quest Diagnostics to Release Second Quarter 2008 Financial Results

(Date:6/19/2013)... The Flemish plant scientist Marc Van Montagu (born 1933) ... with the American scientists Mary-Dell Chilton and Robert T. ... by the US Secretary of State, John Kerry. The ... and agriculture" - gives the award annually to one ... social importance for the quality, quantity or availability of ...

(Date:6/19/2013)... researchers at the University of Pittsburgh has developed ... HIV, that could be potential treatments for drug-resistant ... These new agents are quite small, making them ... published in the June 2013 issue of the ... The first of many probable applications will likely ...

(Date:6/19/2013)... Insulin is the most potent physiological anabolic ... storage and synthesis of lipids, protein and carbohydrates, ... circulatory system. It also plays a major role ... the glucose is metabolized and removed from the ... the precise molecular mechanisms by which insulin regulates ...

Breaking Biology News(10 mins):World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2 World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3 World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4 HIV-derived antibacterial shows promise against drug-resistant bacteria 2 Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2

[0] World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu [0] HIV-derived antibacterial shows promise against drug-resistant bacteria [0] Breakthrough research of essential molecule reveals important targets in diabetes and obesity

... Charles Darwin maintained that the domesticated chicken derives from the ... shows that the wild origins of the chicken are more ... genes that give most domesticated chickens yellow legs and found ... closely related species, the grey jungle fowl. The study ...

... Applauds Option for Voluntary Use of Biometrics, ... a Legal Workforce today applauded the introduction of,legislation ... verification system and to helping prevent unauthorized,employment, a ... The New Employee Verification Act (NEVA) introduced ...

... TEMPE, ARIZ. -- An important discovery has been made with ... by Sandra Pizzarello, a research professor at Arizona State University, ... origin of life on Earth have been shown to carry ... work is being published in this weeks Early Edition of ...

Cached Biology News:Darwin was wrong about the wild origin of the chicken 2 HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 2 HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 3 ASU researcher may have discovered key to life before its origin on Earth 2

Darwin was wrong about the wild origin of the chicken HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System ASU researcher may have discovered key to life before its origin on Earth

...

... siRNA Custom Synthesis Service provides ... RNA to knockdown any gene. ... RNA base pairs with terminal ... or other lengths of your ...

...

Biology Products:

arrayWoRx^e from Applied Precision, LLC 21-mer duplex from B-Bridge International JM101 E. coli Strain from Stratagene BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems